Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe postmenopausal osteoporosis.

Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes.

Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA).

Total hip BMD increases were associated with reduced risk for vertebral and all clinical fractures across active control or sequential therapy trials.

Vitamin D supplementation during pregnancy was not associated with any effects on maternal bone mineral density at 4-year follow-up.

Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.

Across the globe, children with RF-negative polyarticular JIA exhibit differences in clinical features, disease activity, and treatment patterns.

Combination rituximab and IVIG therapy may be a viable treatment option for patients with refractory autoimmune diseases, though the quality of evidence is low.

Idiopathic pulmonary fibrosis was associated with 67,843 deaths in ever-employed persons in the US between 2020 and 2022.

Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

Higher fat and appendicular lean masses were associated with less bone mineral density loss among women in early postmenopause.

Sex hormone decreases over time were associated with decreases in lean mass and physical performance metrics among older men.